Smith Jeffrey T. L.
Insider Reports History
- Location
- Bothell, WA
- Signature
- /s/ Daniel Dex, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Smith Jeffrey T. L.:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zymeworks Inc. | EVP & Chief Medical Officer | Restricted Stock Unit | 35,334 | $790,977 | $14.92 | 12 Jan 2026 | Direct |
| Zymeworks Inc. | EVP & Chief Medical Officer | Common Stock | 26,708 | $605,563 | $22.67 | 12 Jan 2026 | Direct |
Insider Reports Filed by Smith Jeffrey T. L.
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | 12 Jan 2026 | 3 | -$211,090 | 4 | EVP & Chief Medical Officer | 12 Jan 2026, 21:00 |
| ZYME | Zymeworks Inc. | 05 Jan 2026 | 3 | -$264,471 | 4 | EVP & Chief Medical Officer | 05 Jan 2026, 20:22 |
| ZYME | Zymeworks Inc. | 10 Jan 2025 | 2 | $0 | 4 | EVP & Chief Medical Officer | 10 Jan 2025, 18:03 |
| ZYME | Zymeworks Inc. | 06 Jan 2025 | 3 | -$165,807 | 4 | EVP & Chief Medical Officer | 06 Jan 2025, 20:19 |
| ZYME | Zymeworks Inc. | 05 Jan 2024 | 2 | $0 | 4 | EVP & Chief Medical Officer | 08 Jan 2024, 18:00 |
| ZYME | Zymeworks Inc. | 03 Jan 2024 | 0 | $0 | 3 | EVP & Chief Medical Officer | 05 Jan 2024, 18:00 |